+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Distribution - Global Strategic Business Report

  • PDF Icon

    Report

  • 417 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302566
The global market for Healthcare Distribution was valued at US$2.6 Trillion in 2024 and is projected to reach US$5.7 Trillion by 2030, growing at a CAGR of 13.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Healthcare Distribution Market - Key Trends & Drivers Summarized

Healthcare distribution is a critical component of the medical supply chain, ensuring that pharmaceutical products, medical devices, and healthcare supplies are efficiently delivered from manufacturers to healthcare providers and patients. This complex network involves various stakeholders, including wholesalers, distributors, and logistics providers, who coordinate to maintain the integrity and availability of medical products. Healthcare distribution companies are responsible for the storage, handling, and transportation of these products, adhering to stringent regulations and standards to ensure product safety and efficacy. The sector encompasses a wide range of activities, from managing temperature-sensitive medications in cold chain logistics to ensuring timely delivery of life-saving drugs and equipment to hospitals and clinics. Effective healthcare distribution is essential for maintaining the continuous supply of critical medical products, particularly during emergencies and public health crises.

The healthcare distribution industry has evolved significantly with advancements in technology and logistics management. The integration of track-and-trace technologies, such as RFID and blockchain, has improved the transparency and security of the supply chain, reducing the risk of counterfeit products entering the market. The rise of e-commerce and digital health platforms has also transformed healthcare distribution, enabling direct-to-patient delivery models and expanding access to healthcare products. These technological advancements not only streamline operations but also provide better visibility and control over the supply chain, ensuring that healthcare providers and patients receive their products safely and on time.

The growth in the healthcare distribution market is driven by several factors, including increasing demand for pharmaceutical products, advancements in logistics technology, and the expansion of the healthcare sector. The rising prevalence of chronic diseases and an aging population have led to higher consumption of medications and medical supplies, necessitating efficient distribution networks. Technological advancements, such as the implementation of artificial intelligence (AI) and machine learning in predictive analytics, have optimized supply chain operations, enhancing demand forecasting and inventory management. Additionally, the expansion of healthcare infrastructure in emerging markets has increased the need for robust distribution networks to support growing medical needs. The COVID-19 pandemic further underscored the importance of resilient healthcare distribution systems, as the rapid and widespread distribution of vaccines and medical supplies became a global priority. Moreover, regulatory pressures to ensure compliance and the growing trend of personalized medicine are also significant drivers, requiring tailored distribution solutions to meet specific patient needs. These factors collectively contribute to the robust expansion of the healthcare distribution market, ensuring its critical role in the global healthcare ecosystem.

Scope of the Study

The report analyzes the Healthcare Distribution market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Product Type (Pharmaceutical, Biopharmaceutical, Medical Devices); End-Use (Retail Pharmacies, Hospital Pharmacies, Other End Uses).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Pharmaceutical Distribution segment, which is expected to reach US$2.3 Trillion by 2030 with a CAGR of a 13.3%. The Biopharmaceutical Distribution segment is also set to grow at 14.8% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $914.1 Billion in 2024, and China, forecasted to grow at an impressive 15.6% CAGR to reach $1.0 Trillion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Cardinal Health, Inc., Epicor Software Corporation, Henry Schein, Inc., FedEx Corporation, Imperial Logistics Group (Pty) Limited and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Healthcare Distribution Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Healthcare Distribution Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Healthcare Distribution Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 61 major companies featured in this Healthcare Distribution market report include:

  • Cardinal Health, Inc.
  • Epicor Software Corporation
  • Henry Schein, Inc.
  • FedEx Corporation
  • Imperial Logistics Group (Pty) Limited
  • HighJump Software, Inc.
  • CenTrak, Inc.
  • Biolog-id
  • Express Scripts Holding Company
  • AmerisourceBergen Corporation
  • Global Healthcare Exchange LLC (Ghx)
  • Alliance Healthcare
  • Cavalier Logistics
  • Intalere
  • Hvantage Technologies Inc.

Table of Contents

I. METHODOLOGYMII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Healthcare Distribution - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
  • Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
  • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
  • Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
  • Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
  • Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
  • Here’s How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
  • Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
  • Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
  • Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
  • More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
  • Artificial Intelligence to Revolutionize Pharmaceutical Retailing
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Other End Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Healthcare Distribution Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 23: USA Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: USA 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 26: USA Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: USA 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: Canada 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: Canada 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
JAPAN
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: Japan 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Japan 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
CHINA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 41: China Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: China 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 44: China Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: China 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
EUROPE
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Europe 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Europe 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Europe 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
FRANCE
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 56: France Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: France 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 59: France Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: France 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
GERMANY
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Germany 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Germany 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
ITALY
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Italy 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Italy 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 74: UK Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: UK 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 77: UK Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: UK 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
SPAIN
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Spain 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Spain 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
RUSSIA
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Russia 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Russia 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Rest of Europe 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Rest of Europe 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Asia-Pacific 15-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 15-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2015, 2025 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 15-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2015, 2025 & 2030
AUSTRALIA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cardinal Health, Inc.
  • Epicor Software Corporation
  • Henry Schein, Inc.
  • FedEx Corporation
  • Imperial Logistics Group (Pty) Limited
  • HighJump Software, Inc.
  • CenTrak, Inc.
  • Biolog-id
  • Express Scripts Holding Company
  • AmerisourceBergen Corporation
  • Global Healthcare Exchange LLC (Ghx)
  • Alliance Healthcare
  • Cavalier Logistics
  • Intalere
  • Hvantage Technologies Inc.

Table Information